JORGE ARTURO DIAZ MD NPI 1558517987

NPI Details

Jorge Arturo Diaz, MD is a hematology and oncology internal medicine in Huntsville, AL with 22 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jorge Arturo Diaz, MD NPI is 1558517987. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1 HOSPITAL DR SW
HUNTSVILLE, AL
ZIP 35801-455
Phone: (256) 705-4224

The NPI 1558517987 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Nephelometry, test method using light (HCPCS:83883)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Magnesium level (HCPCS:83735)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Phosphate level (HCPCS:84100)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Unclassified drugs (HCPCS:J3490)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Protein measurement, serum (HCPCS:84165)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Automated urinalysis test (HCPCS:81003)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Vitamin d-3 level (HCPCS:82306)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Injection of drug or substance into vein (HCPCS:96374)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Uric acid level, blood (HCPCS:84550)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Folic acid level, serum (HCPCS:82746)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Blood test, clotting time (HCPCS:85610)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Drawing of blood for a medical problem (HCPCS:99195)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Bilirubin level, direct (HCPCS:82248)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Collection of blood sample from implanted device (HCPCS:36591)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Erythropoietin (protein) level (HCPCS:82668)
• Injection, morphine sulfate, up to 10 mg (HCPCS:J2270)

The enumeration date for this NPI number is 8/18/2008 and was last updated on 1/27/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: